News-Medical.Net March 8, 2025
An ambitious project led by Vanderbilt University Medical Center investigators aims to use artificial intelligence technologies to generate antibody therapies against any antigen target of interest.
VUMC has been awarded up to $30 million from the Advanced Research Projects Agency for Health (ARPA-H) to build a massive antibody-antigen atlas, develop AI-based algorithms to engineer antigen-specific antibodies, and apply the AI technology to identify and develop potential therapeutic antibodies.
ARPA-H is an agency within the U.S. Department of Health and Human Services that supports transformative high-risk, high-reward research to drive biomedical and health breakthroughs to benefit everyone.
Over the last few decades, monoclonal antibodies have started playing an important therapeutic role in a wide range of disease settings, but we’re...
Today's Sponsors
Today's Sponsor